Alterations in the Sp1 binding and Fmr-1 gene expression in the cortex of the brain during maturation and aging of mouse

Molecular Biology Reports

Volumn 41, Issue 10, 2014, Pages 6855-6863

  Gaur, Pankaj ^a   Prasad, S ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Aging; Brain aging; Fmr 1; FMRP; Maturation; Sp1; Transcription factors

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR SP1; FMR1 PROTEIN, MOUSE; ISOPROTEIN; PROTEIN BINDING;

ADULT; AGING; ARTICLE; BRAIN CORTEX; BRAIN MATURATION; COGNITIVE DEVELOPMENT; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FMR 1 GENE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; MOUSE; NEWBORN; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; AGE; ANIMAL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM;

MUS;

AGE FACTORS; AGING; ANIMALS; CEREBRAL CORTEX; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; GENE EXPRESSION REGULATION; MICE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN ISOFORMS; RNA, MESSENGER; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 84919401023     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3571-1     Document Type: Article

References (50)

1. Rosenzweig ES, Barnes CA (2003) Impact of aging on hippocampal function: plasticity, network dynamics, and cognition. Prog Neurobiol 69:143–179
2. Kreutz M, König I, Mikhaylova M, Spilker C, Zuschratter W (2008) Molecular Mechanisms of Dendritic Spine Plasticity in Development and Aging. Handbook of neurochemistry and molecular neurobiology: development and aging changes in the nervous system: 245–259
3. Lohmann C, Kessels HW (2014) The developmental stages of synaptic plasticity. J physiol 592:13–31
4. Huber KM, Kayser MS, Bear MF (2000) Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. Science 288:1254–1257
5. Sidorov MS, Auerbach BD, Bear MF (2013) Fragile X mental retardation protein and synaptic plasticity. Mol Brain 6:15
6. Scotto-Lomassese S, Nissant A, Mota T, Neant-Fery M, Oostra BA et al (2011) Fragile X mental retardation protein regulates new neuron differentiation in the adult olfactory bulb. J Neurosci 31:2205–2215
7. Siller SS, Broadie K (2011) Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase. Dis Model Mech 4:673–685
8. Friedman SH, Dani N, Rushton E, Broadie K (2013) Fragile X mental retardation protein regulates trans-synaptic signaling in Drosophila. Dis Model Mech 6:1400–1413
9. Comery TA, Harris JB, Willems PJ, Oostra BA, Irwin SA et al (1997) Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci 94:5401–5404
10. Brackett DM, Qing F, Amieux PS, Sellers DL, Horner PJ et al (2013) FMR1 transcript isoforms: association with polyribosomes; regional and developmental expression in mouse brain. PLoS One 8:e58296
11. Eichler DC, Liberatore JA, Shumard CM (1993) Selection of a preribosomal RNA processing site by a nucleolar endoribonuclease involves formation of a stable complex. Nucleic Acids Res 21:5775–5781
12. Penagarikano O, Mulle JG, Warren ST (2007) The pathophysiology of fragile x syndrome. Annu Rev Genom Hum Genet 8:109–129
13. Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A et al (2011) FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146:247–261
14. Gross C, Berry-Kravis EM, Bassell GJ (2012) Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond. Neuropsychopharmacology 37:178–195
15. Bagni C, Tassone F, Neri G, Hagerman R (2012) Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics. J Clin Investig 122:4314–4322
16. Charalambous DC, Pasciuto E, Mercaldo V, Pilo Boyl P, Munck S et al (2013) KIF1Bbeta transports dendritically localized mRNPs in neurons and is recruited to synapses in an activity-dependent manner. Cell Mol Life Sci 70:335–356
17. Kalidas S, Smith DP (2003) Functional genomics, fragile X syndrome, and RNA interference. Arch Neurol 60:1197–1200
18. Gessert S, Bugner V, Tecza A, Pinker M, Kuhl M (2010) FMR1/FXR1 and the miRNA pathway are required for eye and neural crest development. Dev Biol 341:222–235
19. Gabus C, Mazroui R, Tremblay S, Khandjian EW, Darlix JL (2004) The fragile X mental retardation protein has nucleic acid chaperone properties. Nucleic Acids Res 32:2129–2137
20. De Rubeis S, Bagni C (2010) Fragile X mental retardation protein control of neuronal mRNA metabolism: insights into mRNA stability. Mol Cell Neurosci 43:43–50
21. Zalfa F, Eleuteri B, Dickson KS, Mercaldo V, De Rubeis S et al (2007) A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability. Nat Neurosci 10:578–587
22. Peprah E (2012) Fragile X syndrome: the FMR1 CGG repeat distribution among world populations. Ann Hum Genet 76:178–191
23. Krueger DD, Bear MF (2011) Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu Rev Med 62:411–429
24. De Rubeis S, Fernandez E, Buzzi A, Di Marino D, Bagni C (2012) Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis. Adv Exp Med Biol 970:517–551
25. Kumari D, Gabrielian A, Wheeler D, Usdin K (2005) The roles of Sp1, Sp3, USF1/USF2 and NRF-1 in the regulation and three-dimensional structure of the Fragile X mental retardation gene promoter. Biochem J 386:297–303
26. Smith KT, Nicholls RD, Reines D (2006) The gene encoding the fragile X RNA-binding protein is controlled by nuclear respiratory factor 2 and the CREB family of transcription factors. Nucleic Acids Res 34:1205–1215
27. Carrillo C, Cisneros B, Montanez C (1999) Sp1 and AP2 transcription factors are required for the human fragile mental retardation promoter activity in SK-N-SH neuronal cells. Neurosci Lett 276:149–152
28. Cote F, Schussler N, Boularand S, Peirotes A, Thevenot E et al (2002) Involvement of NF-Y and Sp1 in basal and cAMP-stimulated transcriptional activation of the tryptophan hydroxylase (TPH) gene in the pineal gland. J Neurochem 81:673–685
29. Smith KT, Coffee B, Reines D (2004) Occupancy and synergistic activation of the FMR1 promoter by Nrf-1 and Sp1 in vivo. Hum Mol Genet 13:1611–1621
30. Garber K, Smith KT, Reines D, Warren ST (2006) Transcription, translation and fragile X syndrome. Curr Opin Genet Dev 16:270–275
31. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
32. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
33. Singh K, Gaur P, Prasad S (2007) Fragile x mental retardation (Fmr-1) gene expression is down regulated in brain of mice during aging. Mol Biol Rep 34:173–181
34. Gupta RK, Prasad S (2014) Differential regulation of GLT-1/EAAT2 gene expression by NF-kappaB and N-myc in male mouse brain during postnatal development. Neurochem Res 39:150–160
35. Dignam JD, Lebovitz RM, Roeder RG (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475–1489
36. Prasad S, Singh K (2008) Interaction of USF1/USF2 and alpha-Pal/Nrf1 to Fmr-1 promoter increases in mouse brain during aging. Biochem Biophys Res Commun 376:347–351
37. Berman RF, Murray KD, Arque G, Hunsaker MR, Wenzel HJ (2012) Abnormal dendrite and spine morphology in primary visual cortex in the CGG knock-in mouse model of the fragile X premutation. Epilepsia 53(Suppl 1):150–160
38. Kaplan ES, Cao Z, Hulsizer S, Tassone F, Berman RF et al (2012) Early mitochondrial abnormalities in hippocampal neurons cultured from Fmr1 pre-mutation mouse model. J Neurochem 123:613–621
39. Davidovic L, Navratil V, Bonaccorso CM, Catania MV, Bardoni B et al (2011) A metabolomic and systems biology perspective on the brain of the fragile X syndrome mouse model. Genome Res 21:2190–2202
40. Lu R, Wang H, Liang Z, Ku L, O’Donnell WT et al (2004) The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. Proc Natl Acad Sci USA 101:15201–15206
41. Pan F, Aldridge GM, Greenough WT, Gan WB (2010) Dendritic spine instability and insensitivity to modulation by sensory experience in a mouse model of fragile X syndrome. Proc Natl Acad Sci USA 107:17768–17773
42. Pacey LK, Xuan IC, Guan S, Sussman D, Henkelman RM et al (2013) Delayed myelination in a mouse model of fragile X syndrome. Hum Mol Genet 22:3920–3930
43. Singh K, Prasad S (2008) Differential expression of Fmr-1 mRNA and FMRP in female mice brain during aging. Mol Biol Rep 35:677–684
44. Westmark CJ, Malter JS (2007) FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS Biol 5:e52
45. Wang H, Wu LJ, Kim SS, Lee FJ, Gong B et al (2008) FMRP acts as a key messenger for dopamine modulation in the forebrain. Neuron 59:634–647
46. Tassone F, Beilina A, Carosi C, Albertosi S, Bagni C et al (2007) Elevated FMR1 mRNA in premutation carriers is due to increased transcription. RNA 13:555–562
47. Drouin R, Angers M, Dallaire N, Rose TM, Khandjian EW et al (1997) Structural and functional characterization of the human FMR1 promoter reveals similarities with the hnRNP-A2 promoter region. Hum Mol Genet 6:2051–2060
48. Prasad S, Singh K (2008) Age- and sex-dependent differential interaction of nuclear trans-acting factors with Fmr-1 promoter in mice brain. Neurochem Res 33:1028–1035
49. Doetzlhofer A, Rotheneder H, Lagger G, Koranda M, Kurtev V et al (1999) Histone deacetylase 1 can repress transcription by binding to Sp1. Mol Cell Biol 19:5504–5511
50. Wu J, Xue L, Weng M, Sun Y, Zhang Z et al (2007) Sp1 is essential for p16 expression in human diploid fibroblasts during senescence. PLoS One 2:e164